 Aclaris Therapeutics ACRS stock is soaring higher on Tuesday after revealing results from a recent Phase 2a clinical trial. The post ACRS Stock Alert: Why Aclaris Therapeutics Is Up Over 200 Today appeared first on InvestorPlace. 